Usefulness of Transcutaneous Capnography to Assess Residual Hypoventilation in Obesity-Hypoventilation Syndrom Treated by Non Invasive Ventilation at Home : a Prospective Study
PtcCO2-SOH
1 other identifier
observational
32
1 country
1
Brief Summary
Transcutaneous capnography (PtcCo2) recently showed good agreement with blood gases to assess hypercapnia. There is no study that has evaluated the benefit to realise systematically a nocturnal PtcCo2 in the follow-up of home-ventilated patient with obesity hypoventilation syndrome (OHS). The investigators will evaluate the intake bring by nocturnal transcutaneous capnography, compared to nocturnal oximetry and blood gases, to diagnose nocturnal alveolar hypoventilation in a population of patient presenting an OHS, treated by non invasive ventilation (NIV) at home .
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Aug 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 13, 2018
CompletedFirst Posted
Study publicly available on registry
June 28, 2018
CompletedStudy Start
First participant enrolled
August 14, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 21, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
November 21, 2019
CompletedDecember 24, 2020
November 1, 2020
1.3 years
June 13, 2018
December 22, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
nocturnal hypoventilation
Nocturnal PtcCo2 \> 49 mmHg more than 10% of sleeping time
Until 37 days
Interventions
every patient will be monitored with a blood gase, a nocturnal oximetry and a transcutaneous capnography
Eligibility Criteria
The pneumology department at Nantes University Hospital follows approximately 400 patients treated by non-invasive ventilation, 250 of whom have SOH The investigators plan to include 150 patients in the active patient line followed at Nantes University Hospital, which will make it possible to obtain the number of patients necessary to obtain satisfactory power while taking into account the fact that a certain number of transcutaneous capnographies will not be conclusive.
You may qualify if:
- Obesity Hypoventilation Syndrom defined by a diurnal PaCo2\> 45 mmHg, in stable conditions, in a patient presenting an obesity (BMI \> 30 kg/m²)
- treated by non invasive ventilation since at least 3 weeks, and seen in follow-up consultation
You may not qualify if:
- minors
- refusal to participate
- under guardianship or trusteeship
- pregnant woman
- other etiology of hypoventilation : copd, kyphoscoliosis, neuromuscular disorders, diaphragmatic pathology
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Nantes University Hospital
Nantes, 44093, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 13, 2018
First Posted
June 28, 2018
Study Start
August 14, 2018
Primary Completion
November 21, 2019
Study Completion
November 21, 2019
Last Updated
December 24, 2020
Record last verified: 2020-11
Data Sharing
- IPD Sharing
- Will not share